Drug & supplement interaction

Mindfulness + ADO-Trastuzumab Emtansine

ADO-Trastuzumab Emtansine brand name: Kadcyla.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Mindfulness and ADO-Trastuzumab Emtansine in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone interested in this? Share
Interaction report

Mindfulness and ADO-Trastuzumab Emtansine

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between ADO-Trastuzumab Emtansine and Mindfulness in our sources. This does not guarantee that the combination is completely free of risk — research on Mindfulness alongside specific medications may be limited.

Worth understanding: our licensed dataset holds no drug-interaction record for Mindfulness at all — not against ADO-Trastuzumab Emtansine, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

Mindfulness is a practice rather than something you take. Ask your care team whether the type and intensity you plan to practice are appropriate for your health and treatment. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Mindfulness safety at a glance

Mindfulness overall Generally safe Mindfulness is generally very safe for most people and has no swallowed dose or chemical risk.
Pregnancy Generally safe Mindfulness practices are generally considered safe during pregnancy and may help with stress.
Breastfeeding Generally safe There is no known risk to breastfeeding from practicing mindfulness.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining ADO-Trastuzumab Emtansine and Mindfulness? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Mindfulness Itself Has Been Linked To

This is not an interaction — nothing below involves ADO-Trastuzumab Emtansine. It is the side-effect record for Mindfulness on its own, from the licensed Natural Medicines monograph. If something new turns up after you add Mindfulness, this list is the first place to look. One entry is worth acting on rather than waiting out — marked below.

  • Thoughts of self-harm Worth acting on Additional detail

    “Some studies report rare cases of anger, worsening anxiety, and thoughts of self-harm in patients, but these effects could have been caused by the underlying ailment rather than practicing mindfulness.”

    Mindfulness · Natural Medicines adverse-effect record, reported in anxiety.

    3 sources cited
    1. 100273. Hilton L, Hempel S, Ewing BA, et al. Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Ann Behav Med. 2017;51(2):199-213. PubMed
    2. 105414. Zgierska AE, Burzinski CA, Mundt MP, et al. Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial. J Subst Abuse Treat. 2019 May;100:8-17. PubMed
    3. 109368. Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: A randomized clinical trial. JAMA Psychiatry. 2022:e223679. PubMed
  • Anxiety or restlessness Additional detail

    Recorded for Mindfulness in the same Natural Medicines adverse-effect record shown under Thoughts of self-harm above.

Everything above comes from the Natural Medicines adverse-effect record for Mindfulness — expand a row for the licensed statement it rests on. We read the ADVERSE REACTIONS section of ADO-Trastuzumab Emtansine’s FDA label too, and the two lists don’t meaningfully overlap — which is why no ADO-Trastuzumab Emtansine column appears here.

Everything else you take

See Every Supplement That Interacts With ADO-Trastuzumab Emtansine

This page covers Mindfulness only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the ADO-Trastuzumab Emtansine page lists 121 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate), Adrafinil (moderate) and African Wild Potato (moderate).

By severity: 2 major · 87 moderate · 32 minor.

From our pharmacist’s overview on the ADO-Trastuzumab Emtansine page

“If you're taking ado-trastuzumab emtansine (Kadcyla) for HER2-positive breast cancer, treat this list as one to check carefully, not casually. Every one of the 121 flagged ingredients affects the same enzyme, CYP3A4, which your body uses to clear part of this medicine.”

Reviewed by 2 · Jul 18, 2026

Open the ADO-Trastuzumab Emtansine interaction page

How much people look this up

Where Mindfulness and ADO-Trastuzumab Emtansine Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Mindfulness
Top half

#460 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication ADO-Trastuzumab Emtansine
Top 10%

#147 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Mindfulness reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Mindfulness and ADO-Trastuzumab Emtansine records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Mind-body practice

About Mindfulness

What is Mindfulness?

  • Stress reduction
  • Anxiety and depression
  • Chronic pain
  • Sleep problems
  • Improving focus and emotional well-being

Mindfulness is a mind-body practice—not a pill or herb—that involves paying attention to the present moment without judgment. Research suggests it can modestly help with stress, anxiety, depression, and chronic pain for many people, and it is generally very safe. It is best used alongside, not in place of, care from your doctor or pharmacist.

Not applicable (mind-body practice) · Guided meditation, breathing exercises, body scans, mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT) programs, apps, classes

An interaction check asks whether these two react with each other — it does not ask whether Mindfulness is a good idea for someone in your situation. Here is what our Mindfulness record says about it on its own.

Mindfulness: dosing

There is no standardized "dose" for mindfulness. Many structured programs, such as MBSR, run for about eight weeks with daily home practice, but you do not need a formal program to benefit.A common starting point is a few minutes of practice per day, gradually building up as it feels comfortable. Even short, regular sessions can help.

From our Mindfulness monograph — the full record covers uses, side effects and every documented interaction.

Read the full Mindfulness monograph & all interactions
Medication

About Ado-trastuzumab Emtansine Injection

What Is Ado-trastuzumab Emtansine Injection Used For?

Brand name: Kadcyla

Kadcyla (ado-trastuzumab emtansine) is used on its own to treat HER2-positive metastatic breast cancer in adults who have already received trastuzumab and a taxane chemotherapy, either together or separately. It is used when cancer has come back or spread, or when the disease returned within six months of finishing earlier treatment.

Kadcyla is also used as adjuvant (after-surgery) treatment for HER2-positive early breast cancer in patients who still had remaining cancer after completing neoadjuvant (pre-surgery) treatment with a taxane and trastuzumab. Patients must be tested for HER2 overexpression or gene amplification using an FDA-authorized test before starting Kadcyla.

Most-Reported Side Effects for ADO-Trastuzumab Emtansine

From FAERS, the FDA’s public side-effect reporting system (8,277 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Disease progression 781 reports
Fatigue 751 reports
Nausea 732 reports
Diarrhea 594 reports
Thrombocytopenia 468 reports
See full Ado-trastuzumab Emtansine Injection drug information
Keep checking

Other Drugs & Mindfulness

Browse every other medication we’ve checked against Mindfulness — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Mindfulness References

The 3 references that drive our Mindfulness monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Hilton L, Hempel S, Ewing BA, et al. Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Ann Behav Med. 2017;51(2):199-213. PubMed
  2. Zgierska AE, Burzinski CA, Mundt MP, et al. Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial. J Subst Abuse Treat. 2019 May;100:8-17. PubMed
  3. Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: A randomized clinical trial. JAMA Psychiatry. 2022:e223679. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Practicing Mindfulness While Taking ADO-Trastuzumab Emtansine: Common Questions

Is it safe to practice Mindfulness while taking ADO-Trastuzumab Emtansine?
We do not list a known interaction between Mindfulness and ADO-Trastuzumab Emtansine. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does ADO-Trastuzumab Emtansine interact with any supplements?
Yes. ADO-Trastuzumab Emtansine has documented interactions with 121 supplements in our database — Mindfulness is not one of them. The ADO-Trastuzumab Emtansine interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About ADO-Trastuzumab Emtansine and Mindfulness?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.